The hearing implants market was valued for $1,733.33 million in 2022 and is estimated to reach $3,819.36 million by 2032, exhibiting a CAGR of 8.2% from 2023 to 2032.
A hearing implant is a medical device designed to address severe to profound hearing loss by directly stimulating the auditory system. It is surgically implanted within the ear or cochlea, and bypasses damaged parts of the natural auditory pathway, such as the hair cells, and electronically stimulates the auditory nerve, enabling sound perception. This solution is typically considered when traditional hearing aids are insufficient due to the extent of hearing loss or anatomical limitations. Cochlear implants are prominent examples, consisting of an external processor and internal implant components. The processor captures and processes sound, which is then transmitted to electrodes of the implant for direct stimulation of the auditory nerve. This approach offers improved speech perception and sound awareness, significantly enhancing communication abilities and overall quality of life for individuals with profound hearing impairment.
The hearing implants market is driven by the prevailing cases of hearing disorders and the growth in geriatric population. Furthermore, growth in cases of hearing disorder in the children further drive the market growth. For instance, according to National Institute of Deafness and other Communication Disorders report in 2021, stated that one in eight people in the U.S. (13 percent, or 30 million) aged 12 years or older has hearing loss in both ears, based on standard hearing examinations. About 2 percent of adults aged 45 to 54 have disabling hearing loss. The rate increases to 8.5 percent for adults aged 55 to 64.
Furthermore, the availability of innovative hearing implant technologies further drives the market growth. The advancements encompass features such as improved speech recognition in challenging auditory environments, wireless connectivity, and innovative sound processing algorithms. These innovations cater to diverse user needs and preferences, fostering interest and uptake among a broader audience seeking effective solutions to their hearing impairment.
Moreover, the surge in government initiatives aimed at growing awareness about early treatment options plays a pivotal role. These initiatives underscore the importance of early intervention and the benefits of hearing implants, encouraging individuals to seek prompt medical attention. In addition, the range of available hearing implant options, coupled with the expansion of reimbursement coverage for implantable procedures, has significantly fueled the demand for these devices. The financial accessibility brought about by reimbursement policies has rendered hearing implants a viable solution for a wider demographic, promoting market growth.
However, surgical procedures to implant these devices carry inherent risks, deterring some individuals from opting for them. Moreover, not everyone qualifies as a candidate due to factors such as anatomical limitations or medical conditions. The high cost of hearing implants and related procedures poses a financial barrier for many potential users. In addition, the necessity for ongoing maintenance and potential complications post-implantation can deter adoption. Thus, the aforementioned factors are anticipated to restrain the market growth.
The hearing implants market is segmented based on product, application, end user and region. On the basis of product, the market is categorized into cochlear implant, middle ear implant, bone conduction implant and auditory brainstem implant. On the basis of application, the market is bifurcated into conductive and sensorineural. On the basis of end user, the market is fragmented into hospitals, ENT clinics and ambulatory surgical centers (ASCs). On the basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
Major players that operate in the hearing implants market include Cochlear Limited, Medtronic plc, Envoy Medical, MED-EL, Sonova Holding AG, Zhejiang Nurotron Biotechnology Co., Ltd, Ototronix, LLC, Todoc Co. Ltd, Neubio AG. and Hemideina
A hearing implant is a medical device designed to address severe to profound hearing loss by directly stimulating the auditory system. It is surgically implanted within the ear or cochlea, and bypasses damaged parts of the natural auditory pathway, such as the hair cells, and electronically stimulates the auditory nerve, enabling sound perception. This solution is typically considered when traditional hearing aids are insufficient due to the extent of hearing loss or anatomical limitations. Cochlear implants are prominent examples, consisting of an external processor and internal implant components. The processor captures and processes sound, which is then transmitted to electrodes of the implant for direct stimulation of the auditory nerve. This approach offers improved speech perception and sound awareness, significantly enhancing communication abilities and overall quality of life for individuals with profound hearing impairment.
The hearing implants market is driven by the prevailing cases of hearing disorders and the growth in geriatric population. Furthermore, growth in cases of hearing disorder in the children further drive the market growth. For instance, according to National Institute of Deafness and other Communication Disorders report in 2021, stated that one in eight people in the U.S. (13 percent, or 30 million) aged 12 years or older has hearing loss in both ears, based on standard hearing examinations. About 2 percent of adults aged 45 to 54 have disabling hearing loss. The rate increases to 8.5 percent for adults aged 55 to 64.
Furthermore, the availability of innovative hearing implant technologies further drives the market growth. The advancements encompass features such as improved speech recognition in challenging auditory environments, wireless connectivity, and innovative sound processing algorithms. These innovations cater to diverse user needs and preferences, fostering interest and uptake among a broader audience seeking effective solutions to their hearing impairment.
Moreover, the surge in government initiatives aimed at growing awareness about early treatment options plays a pivotal role. These initiatives underscore the importance of early intervention and the benefits of hearing implants, encouraging individuals to seek prompt medical attention. In addition, the range of available hearing implant options, coupled with the expansion of reimbursement coverage for implantable procedures, has significantly fueled the demand for these devices. The financial accessibility brought about by reimbursement policies has rendered hearing implants a viable solution for a wider demographic, promoting market growth.
However, surgical procedures to implant these devices carry inherent risks, deterring some individuals from opting for them. Moreover, not everyone qualifies as a candidate due to factors such as anatomical limitations or medical conditions. The high cost of hearing implants and related procedures poses a financial barrier for many potential users. In addition, the necessity for ongoing maintenance and potential complications post-implantation can deter adoption. Thus, the aforementioned factors are anticipated to restrain the market growth.
The hearing implants market is segmented based on product, application, end user and region. On the basis of product, the market is categorized into cochlear implant, middle ear implant, bone conduction implant and auditory brainstem implant. On the basis of application, the market is bifurcated into conductive and sensorineural. On the basis of end user, the market is fragmented into hospitals, ENT clinics and ambulatory surgical centers (ASCs). On the basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
Major players that operate in the hearing implants market include Cochlear Limited, Medtronic plc, Envoy Medical, MED-EL, Sonova Holding AG, Zhejiang Nurotron Biotechnology Co., Ltd, Ototronix, LLC, Todoc Co. Ltd, Neubio AG. and Hemideina
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hearing implants market analysis from 2022 to 2032 to identify the prevailing hearing implants market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the hearing implants market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global hearing implants market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By End User
- Hospitals
- ENT Clinics
- Ambulatory Surgical Centers
By Product
- Bone Conduction Devices
- Middle Ear Implants
- Auditory Brain Stem Implants
- Cochlear Implants
By Application
- Sensorineural
- Conductive
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Sonova Holding AG
- Todoc co. ltd
- Hemideina
- Neubio AG.
- Cochlear Limited
- Medtronic plc
- Ototronix, LLC
- Envoy Medical
- MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.
- Zhejiang Nurotron Biotechnology Co., Ltd
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: HEARING IMPLANTS MARKET, BY PRODUCT
CHAPTER 5: HEARING IMPLANTS MARKET, BY APPLICATION
CHAPTER 6: HEARING IMPLANTS MARKET, BY END USER
CHAPTER 7: HEARING IMPLANTS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, the hearing implants market was valued at $1.7 billion in 2022, and is estimated to reach $3.8 billion by 2032, growing at a CAGR of 8.2% from 2023 to 2032.The hearing implants market is likely to experience a significant growth rate of 8.2% from 2023-2032 owing to increasing market demand of cochlear implant segment
Hearing implants are medical devices designed to restore or enhance hearing in individuals with severe to profound hearing loss. These implants work by bypassing damaged or non-functional parts of the inner ear and directly stimulating the auditory nerve, allowing users to perceive sound. A typical hearing implant consists of an external microphone and sound processor that captures and processes sounds, transmitting the signals to an internal implant surgically placed beneath the skin. The internal component then delivers electrical impulses to the auditory nerve, enabling recipients to experience a sense of sound, thereby improving their ability to communicate and engage with the world around them.Aging has a direct effect on the functioning of ears. These effects result from various factors, such as wear and tear caused by the overuse of larynx, exposure to loud noise, and cumulative effect of infections. For instance, WHO, in 2022, stated that 1 in every 6 people in the world is expected to be 60 years or older by 2030. In addition, according to the article published in National Library of Medicine, in 2021, stated that out of 2,956, older people in the U.S. who participated in population-based cohort study, 973 (33 %) had normal hearing, 1170 (40%) had mild hearing impairment, 692 (23%) had moderate hearing impairment, and 121 (4%) had severe hearing impairment. Thus, incidence of hearing disorders increases with age, and thereby potentially drives market growth.
Furthermore, the presence of insurance coverage for hearing implants plays a significant role in driving market growth. It enhances accessibility to these life-changing devices for individuals with hearing impairment. Insurance coverage reduces the financial burden on patients, making hearing implants a more viable and attractive option. As a result, a broader segment of the population can afford these implants, increasing demand and market expansion. This, in turn, encourages innovation and competition among manufacturers, spurring advancements in hearing implant technology and driving overall market growth as the healthcare industry responds to the growing need for hearing solutions. For instance, Kanso Sound Processor (developed by Cochlear Ltd. in September) provides a distinct new way for cochlear implant users to hear. The device combines dual-microphone technologies with auditory scene classifier, which automatically adjusts sound processing to different listening environments. Thus, the device provides an effortless hearing experience to users. Furthermore, technological innovations have led to the development of small, miniaturized hearing implants. This has increased the adoption rate of hearing implants in recent years.
Moreover, the growing awareness of hearing loss and the increased availability of customization and personalization options in hearing implants are two pivotal factors driving the remarkable growth of the hearing implant market. As awareness campaigns and educational initiatives continue to gain momentum, individuals are becoming more informed about the consequences of untreated hearing loss and the solutions available to them. This heightened awareness prompts more people to seek professional help and consider hearing implants as a viable treatment option.
In addition, customization and personalization play a significant role in catering to the diverse needs of individuals with hearing loss. Modern hearing implant technologies allow audiologists and surgeons to tailor the devices to the unique requirements of each patient, accounting for factors such as the type and degree of hearing loss, lifestyle, and personal preferences. This level of customization not only enhances the effectiveness of the implants but also increases patient satisfaction, making the decision to undergo implantation more appealing. As a result, the combination of awareness and personalization has a synergistic effect, bolstering the growth of the hearing implants market and improving the quality of life for those with hearing impairment.
The global hearing implants market is segmented into product, application, end user and region. On the basis of product, the market is categorized into cochlear implant, middle ear implant, bone conduction implant and auditory brainstem implant. On the basis of application, the market is bifurcated into conductive and sensorineural. On the basis of end user, the market is fragmented into hospitals, ENT clinics and ambulatory surgical centers (ASCs). On the basis of region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The report provides a comprehensive analysis of the key players that operate in the global hearing implants market such as Cochlear Limited, Medtronic plc, Envoy Medical, MED-EL, Sonova Holding AG, Zhejiang Nurotron Biotechnology Co., Ltd, Ototronix, LLC, Todoc Co. Ltd, Neubio AG. and Hemideina. The key players have adapted acquisition and clinical trials as the strategies to enhance its product portfolio.
Key Market Insights
- On the basis of product type, the cochlear implant segment held the largest market share in 2022. However, the bone conduction implant segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of application, the sensorineural segment held the largest market share in 2022. However, the conductive segment is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of end user, the hospitals segment held the largest market share in 2022. However, the ambulatory surgical centers segment is anticipated to grow at the fastest CAGR during the forecast period.
- Region-wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Sonova Holding AG
- Todoc co. ltd
- Hemideina
- Neubio AG.
- Cochlear Limited
- Medtronic plc
- Ototronix, LLC
- Envoy Medical
- MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.
- Zhejiang Nurotron Biotechnology Co., Ltd
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
